Can a common drug shrink rare facial tumors in kids?
NCT ID NCT03243019
First seen Jan 05, 2026 · Last updated Jun 11, 2026 · Updated 24 times
Summary
This study tests whether the drug rapamycin can reduce the size of large, hard-to-treat lymphatic malformations in the face and neck of children. About 28 kids aged 0 to 18 will take rapamycin by mouth for 6 months. The main goal is to see if the malformations shrink by at least one-fifth, which could ease breathing, swallowing, and pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hu Robert Debre Aphp - Paris
RECRUITINGParis, France
-
Hôpital Jeanne de Flandres, CHU
RECRUITINGLille, France
Contact
Conditions
Explore the condition pages connected to this study.